HF 1183
  • Introduced
    Feb 18, 2021
  • Passed House
  • Passed Senate
  • Became Law
HF 1183
Minnesota House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Excessive drug price increases prohibited by manufacturers to generic or off-patent drugs, attorney general authorized to take action against manufacturers for price increases, withdrawal of generic or off-patent drug sales prohibited, and civil penalties imposed.
Last Action See all actions
House • Apr 09, 2021: Author stricken Boe
Latest Bill Text See all bill texts
2nd Engrossment

Summary

Comments on HF 1183

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Apr 09, 2021 | House
    • Author stricken Boe
  • Mar 25, 2021 | House
    • Author added Greenman
  • Mar 11, 2021 | House
    • Committee report, to adopt and re-refer to Ways and Means
  • Mar 09, 2021 | House
    • Committee - State Government Finance and Elections
  • Mar 08, 2021 | House
    • Author added Klevorn
  • Mar 04, 2021 | House
    • Committee report, to adopt as amended and re-refer to State Government Finance and Elections
    • Author added Bierman
  • Mar 02, 2021 | House
    • Committee - Health Finance and Policy
  • Feb 25, 2021 | House
    • Committee report, to adopt as amended and re-refer to Health Finance and Policy
    • Author added Boe
  • Feb 24, 2021 | House
    • Committee - Commerce Finance and Policy
  • Feb 23, 2021 | House
    • Committee - Commerce Finance and Policy
  • Feb 18, 2021 | House
    • Introduction and first reading, referred to Commerce Finance and Policy
Bill Texts
Documents
Sources